CAS 10417-94-4PubChem CID 446284
Icosapent
All-cis-5,8,11,14,17-icosapentaenoic acid is an icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17. It has a role as a micronutrient, an antidepressant, an antineoplastic agent, an anticholesteremic drug, a nutraceutical, a mouse metabolite, a fungal metabolite and a Daphnia galeata metabolite. It is an omega-3 fatty acid and an icosapentaenoic acid. It is a conjugate acid of an all-cis-5,8,11,14,17-icosapentaenoate. — ChEBI
- IUPAC name
- (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid
- Molecular formula
- C20H30O2
- Molecular weight
- 302.5 g/mol
- Exact mass
- 302.224580195 Da
- XLogP3
- 5.6
- Topological polar surface area
- 37.3 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 2
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
EPAIcosapentoIcosapentumMiraxionEye QEye-QRopufa 70Incromega e 7010sr
16 more reported names
CCRIS 3279AAN7QOV9EAUNII-AAN7QOV9EAIcosapento [INN-Spanish]EPA 45GEPA [drug]C20:5 (n-3)(5Z,8Z,11Z,14Z,17Z)-EicosapentaenoateIcosapentum [INN-Latin]CHEBI:28364C20:5n-3,6,9,12,15EPA (drug)Icosapentum (INN-Latin)Icosapento (INN-Spanish)RELIVENEPA-FFA
External database identifiers
- ChEBI:CHEBI:28364
- ChEMBL:CHEMBL460026
- EPA DTXSID:DTXSID9041023
- PubMed:29968805
- PubMed:21683321
- PubMed:20671299
- PubMed:15753205
- PubMed:15619630
- PubMed:15519495
- PubMed:11347965
Evidence from additional scientific databases
EMBL-EBI ChEBI
Exact identifier matchCHEBI:28364
all-cis-5,8,11,14,17-icosapentaenoic acid
An icosapentaenoic acid having five cis-double bonds at positions 5, 8, 11, 14 and 17.
- Formula
- C20H30O2
- Average mass
- 302.458 g/mol
- Monoisotopic mass
- 302.22458 Da
- Formal charge
- 0
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- antiviral agent — has role (CHEBI:22587)
- renoprotective agent — has role (CHEBI:231911)
- immunosuppressive agent — has role (CHEBI:35705)
- anti-obesity agent — has role (CHEBI:74518)
- micronutrient — has role (CHEBI:27027)
- nutraceutical — has role (CHEBI:50733)
- Daphnia galeata metabolite — has role (CHEBI:83038)
- anticholesteremic drug — has role (CHEBI:35821)
- mouse metabolite — has role (CHEBI:75771)
- antineoplastic agent — has role (CHEBI:35610)
- antidepressant — has role (CHEBI:35469)
- fungal metabolite — has role (CHEBI:76946)
- geroprotector — has role (CHEBI:176497)
- antirheumatic drug — has role (CHEBI:35842)
- anti-asthmatic agent — has role (CHEBI:65023)
- antipsychotic agent — has role (CHEBI:35476)
- cardiovascular drug — has role (CHEBI:35554)
- anticonvulsant — has role (CHEBI:35623)
- anti-inflammatory agent — has role (CHEBI:67079)
- gastrointestinal drug — has role (CHEBI:55324)
- icosapentaenoic acid — is a (CHEBI:36006)
- ω−3 fatty acid — is a (CHEBI:25681)
- all-cis-5,8,11,14,17-icosapentaenoate — is conjugate acid of (CHEBI:58562)
- 11421736 Source: PubMed
- 12549599 Source: PubMed
- 16643058 Source: PubMed
- 17420205 Source: PubMed
- 18459759 Source: PubMed
- 18638380 Source: PubMed
- 19036594 Source: PubMed
- 19054597 Source: PubMed
- 20014752 Source: PubMed
- 21118482 Source: PubMed
- 21274596 Source: PubMed
- 21903399 Source: PubMed
- 22260081 Source: PubMed
- 22822908 Source: PubMed
- 23920312 Source: PubMed
- 24108131 Source: PubMed
- 24238887 Source: PubMed
- 24351031 Source: PubMed
- 24387137 Source: PubMed
- 24389665 Source: PubMed
- 26784936 Source: PubMed
- 31483660 Source: PubMed
- 31618024 Source: PubMed
- 33378197 Source: PubMed
Additional curated names
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid5,8,11,14,17-EICOSAPENTAENOIC ACID5,8,11,14,17-Icosapentaenoic acid(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-eicosapentaenoic acid(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoate(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acidAll-cis-fatty acid 20:5 omega-3C20:5 (n-3)Eicosapentaenoic acidEicosapentaenoic acid (c20:5 n3)(all-Z)-5,8,11,14,17-eicosapentaenoic acidEPAEPA 45Gall-cis-5,8,11,14,17-eicosapentaenoic acidall-cis-icosa-5,8,11,14,17-pentaenoic acidcis-5,8,11,14,17-eicosapentaenoic acidcis-5,8,11,14,17-EPAcis, cis, cis, cis, cis-eicosa-5,8,11,14,17-pentaenoic acidcis-Delta(5,8,11,14,17)-eicosapentaenoic acidicosapentIcosapentaenoic acidIncromega e 7010srRopufa 70Timnodonic acid
Cross-references from this source
- CAS: 10417-94-4 — KEGG COMPOUND
- CAS: 10417-94-4 — ChemIDplus
- REGISTRY_NUMBER: 1714433 — Reaxys
- MANUAL_X_REF: 3174 — DrugCentral
- MANUAL_X_REF: C00000408 — KNApSAcK
- MANUAL_X_REF: C00001215 — KNApSAcK
- MANUAL_X_REF: C06428 — KEGG COMPOUND
- MANUAL_X_REF: D08061 — KEGG DRUG
- MANUAL_X_REF: DB00159 — DrugBank
- MANUAL_X_REF: EICOSAPENTAENOATE — MetaCyc
- MANUAL_X_REF: EPA — PDBeChem
- MANUAL_X_REF: HMDB0001999 — HMDB
- MANUAL_X_REF: LMFA01030759 — LIPID MAPS
Mapped by: Exact CAS cross-reference in the ChEBI compound record. Source updated: 2018-03-05. Retrieved: 2026-08-31. Open source record
NIH PubChem PUG-View
Exact identifier match446284
Attributed physical-property, hazard, environmental and use annotations.
- LogP: 6.1 Source: DrugBank
- Physical Description: Liquid Source: Human Metabolome Database (HMDB)
- Signal: Danger Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P260, P264, P280, P301+P330+P331, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P363, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 92 reports by companies from 1 notifications to the ECHA C&L Inventory.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record
Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.
Additional source coverage and match status
| Source | Result | Checked |
|---|---|---|
| EMBL-EBI ChEBI | Exact match | 2026-08-31 |
| NIH PubChem PUG-View | Exact match | 2026-08-31 |
A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.